Healthcare Pricing, Value and Reimbursement

Introduction

Pricing in healthcare is not simply the act of attaching a monetary amount to a consultation, procedure, medicine, or insurance product. It is a managerial decision that connects clinical resources, patient access, perceived value, payer rules, provider sustainability, and ethical obligations. Unlike many consumer markets, healthcare demand is often mediated by physicians, insurers, employers, governments, and family members. Patients may not know the price before treatment, may not choose the service directly, and may be unable to postpone care safely. These conditions make healthcare pricing both strategically complex and socially consequential.

A healthcare organization must therefore answer several linked questions: What does the service cost to produce? What are competitors charging? How sensitive are patients and payers to price? What outcomes and experiences do patients value? Who actually pays? What reimbursement mechanism will be used? Does the price support equitable access and high-quality care?

This chapter examines cost-, competition-, demand-, and value-based pricing; price sensitivity and transparency; affordability and insurance; reimbursement systems; bundled payments and value-based care; and ethical pricing governance.

Learning Objectives

By the end of this chapter, the learner should be able to:

1. Distinguish major healthcare pricing approaches and select an appropriate approach for a given service.
2. Explain price sensitivity, elasticity, affordability, transparency, and the effects of insurance design.
3. Compare fee-for-service, capitation, diagnosis-related groups, bundled payments, and value-based contracts.
4. Calculate basic cost-plus prices, contribution margins, break-even volumes, and price elasticity.
5. Design pricing and reimbursement decisions that align financial sustainability with patient value, quality, equity, and ethical standards.
6. Evaluate the managerial and governance implications of digital tools, data analytics, and artificial intelligence in pricing.

1. Why Healthcare Pricing Is Different

In a conventional market, the buyer commonly selects a product, observes its price, and pays directly. Healthcare differs in five important ways.

First, the decision maker and payer may be different. A clinician may order a diagnostic test, an insurer may determine the reimbursable amount, and the patient may pay a deductible or co-payment. This separation creates a third-party payment problem: the person consuming the service may not bear its full marginal price.

Second, demand can be urgent and uncertain. Emergency treatment has few substitutes at the moment of need. Patients may accept a high price because delay risks serious harm. Conversely, elective services may be postponed, compared, or obtained from another provider.

Third, quality is difficult to observe in advance. Patients frequently use reputation, accreditation, physician referrals, waiting time, convenience, and outcomes as signals of quality. A low price can signal affordability, but in some contexts it can also signal inferior quality.

Fourth, prices are institutionally constrained. Public fee schedules, insurance contracts, professional regulations, competition law, and reimbursement policies limit managerial discretion.

Fifth, healthcare has a social objective. Providers have responsibilities relating to access, non-discrimination, safety, informed choice, and stewardship of scarce resources. Profitability is important for organizational continuity, but it is not the only legitimate objective.

A useful managerial distinction is between three prices:

• List price: the stated or posted charge.
• Contracted price: the amount agreed with an insurer, employer, government program, or network.
• Patient responsibility: the amount ultimately paid by the patient, including deductibles, co-payments, co-insurance, and non-covered charges.

These amounts may differ substantially. Confusing them produces misleading communication and poor financial forecasts.

2. The Strategic Pricing Process

A sound pricing decision normally follows six stages:

1. Define the service and target segment. A hospital admission, teleconsultation, chronic-care program, and cosmetic procedure have different purchasers, risks, and alternatives.
2. Identify the payer and payment rules. Determine whether revenue comes from a patient, insurer, employer, government, donor, or a combination.
3. Estimate costs and capacity. Separate fixed, variable, direct, indirect, avoidable, and opportunity costs.
4. Assess demand and competition. Examine substitutes, referral patterns, local capacity, waiting times, quality signals, and price sensitivity.
5. Specify the value proposition. Relate price to outcomes, safety, access, convenience, experience, and total cost of care.
6. Test, govern, and review. Monitor utilization, margins, outcomes, complaints, equity indicators, denials, and unintended behavior.

Pricing should be treated as a portfolio decision rather than an isolated transaction. A hospital may accept a low margin on primary care because it supports prevention and continuity, while pricing specialized services to recover capital costs. Such cross-subsidies should be intentional, transparent, and consistent with the organization’s mission.

3. Major Pricing Approaches

3.1 Cost-Based Pricing

Cost-based pricing begins with the resources required to deliver a service and adds a margin or markup. It is useful when costs are measurable, demand is relatively stable, and the organization has a clear financial sustainability objective.

A simple cost-plus price is:

where P is the price per service, C is the relevant cost per service, and M is the monetary margin per service. If the margin is expressed as a markup rate m on cost:

For example, if the relevant cost of a day-care procedure is $800 and the desired markup is 25%, then:

The units are monetary units per procedure. The calculation assumes that the cost base is correctly measured and that the markup is applied consistently.

Cost-based pricing is transparent and administratively simple, but it has limitations. It may ignore what patients value, what payers will reimburse, competitor prices, and the possibility that high costs reflect inefficiency. It can also reward cost inflation when reimbursement is linked mechanically to reported costs.

Healthcare managers should distinguish full cost from incremental cost. Full cost allocates fixed and shared overhead; incremental cost is the additional cost caused by accepting one more patient or service. For short-run decisions with unused capacity, incremental cost may be relevant. For long-run sustainability, the organization must recover an appropriate share of fixed costs.

3.2 Competition-Based Pricing

Competition-based pricing uses comparable providers, negotiated rates, public fee schedules, and market positioning as reference points. A provider may choose a price below competitors to gain volume, near the market median to remain conventionally positioned, or above competitors when it offers demonstrable differentiation.

Competition-based pricing is most useful where:

• patients can compare providers;
• services are standardized;
• capacity and quality are reasonably comparable; and
• payer networks use market benchmarks.

It is less reliable when a provider has a distinctive clinical capability or when competitors’ prices reflect hidden subsidies, different case mixes, or different quality levels. Matching a competitor’s charge without understanding its cost structure can create losses.

3.3 Demand-Based Pricing

Demand-based pricing recognizes that willingness to pay varies by urgency, segment, time, convenience, and perceived scarcity. A private diagnostic center may charge differently for same-day access, home collection, evening appointments, or employer-sponsored packages, provided the distinctions are transparent, lawful, and ethically defensible.

The central analytical concept is price elasticity of demand:

where E_d is price elasticity, Q is quantity demanded, and P is price. In the usual case, elasticity is negative because quantity demanded decreases as price increases. For interpretation, managers often use its absolute value, |E_d|. If |E_d| > 1, demand is elastic; if |E_d| < 1, demand is inelastic; and if |E_d| = 1, demand is unit elastic.

For a finite change, the midpoint method reduces dependence on the starting point:

The formula assumes that other major determinants of demand are sufficiently stable over the period examined. It should not be interpreted as proof that price alone caused the change.

Worked example. A clinic increases its consultation price from $50 to $55, while monthly consultations fall from 1,000 to 900.

Percentage change in quantity = (900 − 1,000) ÷ 1,000 = −10%.

Percentage change in price = (55 − 50) ÷ 50 = 10%.

Using the simple percentage method, E_d = −10% ÷ 10% = −1.0. Demand is approximately unit elastic over this interval. Revenue remains approximately unchanged: before the change, $50 × 1,000 = $50,000; after the change, $55 × 900 = $49,500. The small difference illustrates that elasticity estimates and revenue effects depend on the exact data and method.

Healthcare demand is often heterogeneous. Insured patients may be less sensitive to the listed price than uninsured patients, while all patients may remain sensitive to travel time, waiting time, and perceived quality. Managers should estimate elasticity by segment rather than rely on a single average.

3.4 Value-Based Pricing

Value-based pricing sets price in relation to the benefits created for patients, payers, and sometimes the broader health system. Benefits may include improved survival, fewer complications, faster recovery, reduced travel, greater convenience, or lower total cost of care.

Value is not identical to clinical effectiveness. A treatment may be clinically effective but poorly valued if it is inaccessible, excessively inconvenient, or unaffordable. Conversely, a service that improves coordination and prevents avoidable admissions may create substantial system value even if its immediate revenue is modest.

A practical value assessment considers:

• outcomes relative to relevant alternatives;
• safety and reliability;
• patient-reported outcomes and experience;
• time saved and convenience;
• downstream utilization and total cost of care;
• equity and distribution of benefits; and
• uncertainty in the evidence.

Value-based pricing requires credible measurement. If outcome definitions are vague or data are incomplete, the price claim becomes marketing rather than evidence-based management.

4. Cost, Margin, Capacity, and Break-Even Analysis

A basic contribution model supports short- and medium-term pricing decisions. Contribution per unit is:

where CM is contribution margin per service, P is price or net reimbursement per service, and V is variable cost per service. If fixed costs are F, the break-even volume is:

This formula assumes a constant unit price, constant variable cost, a single service or stable service mix, and that all units produced can be sold. It is not a substitute for a full financial model.

Worked example. A telehealth program has annual fixed costs of $240,000. Net reimbursement is $80 per consultation and variable cost is $32. Therefore:

The program must deliver 5,000 consultations annually to cover the specified costs. At 6,000 consultations, operating contribution after fixed costs is (6,000 × $48) − $240,000 = $48,000.

In practice, managers must adjust for payer mix, denial rates, no-shows, clinician capacity, overtime, quality costs, and the possibility that additional volume reduces service quality.

5. Price Sensitivity, Transparency, and Affordability

Price Sensitivity

Price sensitivity reflects the extent to which a person’s purchase or utilization decision changes when the financial burden changes. It depends on income, urgency, insurance coverage, availability of substitutes, trust, perceived quality, and information.

A patient’s response may concern more than the nominal price. Total economic burden includes transport, time away from work, childcare, medication, follow-up visits, and the risk of an unexpected bill. Hence, a service with a low consultation fee may be unaffordable when ancillary costs are high.

Price Transparency

Transparency means providing understandable, timely, and accurate information about expected charges, coverage, exclusions, patient responsibility, and uncertainty. Effective transparency should:

• distinguish list, negotiated, and patient prices;
• disclose assumptions and likely additional services;
• use plain language and accessible formats;
• provide estimates before elective care where feasible;
• explain how deductibles and co-insurance affect payment; and
• offer a contact route for questions and disputes.

Transparency alone does not guarantee affordability. A patient may know the price and still be unable to pay. Nor is a price estimate a promise when clinical uncertainty makes additional treatment possible. The organization should communicate ranges and decision points rather than create false precision.

Affordability and Financial Hardship

Affordability is a distributional issue. A uniform price may affect households very differently. Ethical responses may include sliding scales, income-based assistance, payment plans, charity care, transport support, generic substitution, and referral to public programs. These mechanisms should be governed by clear eligibility criteria and protected against humiliating or discriminatory administration.

A useful managerial indicator is the share of patients who delay, abandon, or ration recommended care because of cost. Financial counseling and screening should occur early, not only after a bill becomes overdue. Organizations should also examine whether collection practices disproportionately affect vulnerable groups.

6. Insurance and the Reimbursement Architecture

Insurance pools financial risk across members. The insured person pays a premium or is covered through an employer or public program, while the insurer pays some or all eligible costs according to the policy. Common patient cost-sharing mechanisms include:

• Deductible: amount paid by the patient before insurance begins paying under specified conditions.
• Co-payment: fixed amount per service or episode.
• Co-insurance: percentage of an allowed amount paid by the patient.
• Out-of-pocket maximum: contractual limit on specified patient spending during a period.
• Network: providers with agreed terms under the insurance plan.
• Prior authorization: payer approval required before selected services.

Insurance changes incentives. When patients pay less at the point of use, utilization may increase; when providers are paid per service, the incentive to increase volume may also rise. These are not inherently undesirable—necessary care should be used—but they make appropriateness, fraud control, and quality measurement important.

A reimbursement system should be evaluated across four dimensions:

1. Adequacy: Does payment cover efficient resource use and necessary capital?
2. Predictability: Can the provider forecast revenue and cash flow?
3. Alignment: Does payment encourage appropriate quality and outcomes?
4. Equity: Does it avoid excluding high-need or financially vulnerable patients?

7. Reimbursement Models

Fee-for-Service

Fee-for-service is administratively familiar and can support access to specialist capacity. However, it may reward activity rather than health improvement. Fragmented billing also makes the patient’s total cost difficult to understand.

Capitation

Under capitation, a provider receives a fixed amount per enrolled person per period, often adjusted for age, morbidity, and other risk factors. The organization bears more utilization risk and therefore has an incentive to invest in prevention, triage, and care coordination. Inadequate risk adjustment can penalize providers serving complex populations.

Case-Based Payment

A diagnosis-related group or comparable case-based system pays a predetermined amount for a hospitalization classified by diagnosis, procedures, severity, and other factors. Efficient treatment can generate a surplus, while unusually costly cases can generate a loss. Accurate coding and safeguards for readmissions, complications, and premature discharge are essential.

Bundled Payments

A bundle combines payments for services connected to a defined clinical episode, such as joint replacement and specified follow-up care. The episode must be precisely defined: included providers, time window, exclusions, quality requirements, and treatment of complications. Bundles can reduce duplication and encourage coordination, but they require data sharing, contractual clarity, and fair allocation of risk.

Value-Based Care Contracts

Value-based care links payment to outcomes, patient experience, process quality, or total cost of care. A robust contract should specify:

• outcome and process measures;
• data sources and attribution rules;
• risk adjustment;
• performance periods and benchmarks;
• minimum volume and statistical reliability;
• sharing of savings and losses;
• protections against patient selection; and
• appeal and audit procedures.

A narrow indicator can create tunnel vision. For example, rewarding appointment speed without measuring appropriateness may increase unnecessary visits. Measures should therefore be balanced across outcomes, safety, experience, equity, and cost.

8. The Relationship Between Pricing and Value

A central distinction is between price, cost, and value:

• Price is the amount charged or reimbursed.
• Cost is the resource consumption required to produce the service.
• Value is the meaningful benefit relative to alternatives and resources used.

A service can have a high price but low value if outcomes are poor or cheaper alternatives perform equally well. It can also have a low price but high value if it prevents expensive complications. Managers should evaluate value at multiple levels:

• Patient level: health outcomes, experience, convenience, and financial burden.
• Provider level: quality, productivity, workforce sustainability, and financial viability.
• Payer level: appropriateness, total cost, and population outcomes.
• Societal level: equity, public health, productivity, and opportunity cost.

Cost-effectiveness analysis can support these comparisons. The incremental cost-effectiveness ratio is:

where C₁ and C₀ are costs of the new and comparator interventions, and E₁ and E₀ are their corresponding effects, measured in the same outcome unit. The formula is meaningful only when costs and effects are defined consistently, the comparator is appropriate, and uncertainty is reported. An ICER is not itself a price and does not determine whether a service should be funded without considering budget impact, equity, severity, and institutional or societal values.

9. Ethical and Regulatory Governance

Ethical pricing requires more than legal compliance. Important principles include:

Fairness and non-discrimination. Prices should not exploit illness, disability, age, race, gender, geography, or low bargaining power. Differential pricing may be justified by transparent cost or access objectives, but not by arbitrary exclusion.

Non-exploitation. Emergency situations and information asymmetry create opportunities for abuse. Providers should avoid excessive charges, surprise billing, coercive upselling, and unnecessary services.

Respect for autonomy. Patients need understandable information about alternatives, expected benefits, risks, and financial implications. Financial considerations should not corrupt clinical recommendations.

Confidentiality and data governance. Pricing analytics may use clinical, demographic, and behavioral data. Use must be lawful, proportionate, secure, and limited to legitimate purposes. Sensitive data should not be used to impose hidden prices or deny necessary care.

Professional independence. Incentive plans should not pressure clinicians to recommend services primarily because they are profitable. Clinical appropriateness must remain primary.

Accountability. A pricing committee or governance board should review high-impact changes, vulnerable-patient effects, complaints, denials, access metrics, and conflicts of interest. Auditable records should explain how prices and contract terms were determined.

Regulatory obligations vary by jurisdiction and may concern competition, insurance, consumer protection, emergency care, medical billing, privacy, procurement, and public-sector pricing. Managers must obtain current jurisdiction-specific advice rather than assume that a general commercial practice is permissible in healthcare.

10. Technology and Artificial Intelligence in Pricing

Digital systems can improve estimation of demand, staffing, denial risk, and expected resource use. Predictive models may help identify patients at risk of non-attendance or financial hardship, allowing supportive outreach. However, models can reproduce historical inequities if past access or billing patterns reflect discrimination.

Responsible use requires:

• a clearly defined purpose;
• representative and quality-controlled data;
• testing for disparate impact;
• explainable outputs for affected staff and patients;
• human review of high-consequence decisions;
• monitoring for drift;
• cybersecurity and privacy controls; and
• an appeal or correction pathway.

Dynamic pricing requires particular caution. Adjusting prices according to time or capacity may be acceptable for non-urgent elective services when disclosed and equitable. It is ethically problematic when a patient’s medical urgency or vulnerability is used to extract excessive payment. AI should support—not replace—clinical, financial, and ethical judgment.

11. Applied Case: Integrated Knee-Replacement Bundle

The following is a fictional illustrative case.

Background

Riverview Medical Center, a 250-bed hospital, performed approximately 600 elective knee replacements annually. Payment was largely fee-for-service. The hospital, surgeons, physiotherapists, and post-acute providers operated under separate contracts. Patients reported difficulty understanding total costs, and the payer observed variation in length of stay, readmissions, and rehabilitation use.

Problem

The hospital proposed a 90-day bundled payment covering preoperative assessment, surgery, inpatient care, standard implants, discharge planning, specified rehabilitation, and treatment of defined complications. The payer wanted lower total episode cost, while providers feared that a fixed payment would shift excessive risk to them.

Analysis

A multidisciplinary team first established the episode definition and baseline data. The mean historical allowed cost was $18,500 per episode, but variation was substantial. The team identified avoidable delays, duplicated testing, inconsistent discharge criteria, and preventable readmissions. It also found that complex patients were more costly and that a simple average payment could encourage selection against them.

The team therefore considered risk adjustment, stop-loss protection for exceptionally costly cases, and quality gates. Proposed measures included 90-day complication rate, readmissions, patient-reported functional improvement, timely follow-up, and equity of access. The bundle would not produce savings if quality fell below agreed thresholds.

Approach and Solution

The parties set a base episode payment of $18,000, subject to annual review and risk adjustment. Savings below a benchmark could be shared if quality thresholds were met; losses above the benchmark would initially be shared within a limited corridor. The contract clarified which complications were included, how unrelated events would be handled, and how providers would allocate payment internally.

Operational changes included a joint preoperative education program, standardized implant protocols based on clinical evidence, coordinated discharge planning, a telephone follow-up pathway, and a patient-facing cost estimate. A financial counselor reviewed expected patient responsibility before elective admission.

Outcome

After the first year, the organization reported a reduction in average length of stay and fewer duplicated tests. Patient-reported understanding of the care pathway improved. The first-year results were treated as preliminary because case mix, staffing, and referral patterns had changed. The contract was revised to improve risk adjustment and to add an access measure for patients from underserved areas.

Learning Points

1. A bundle is a clinical and contractual design, not merely a single price.
2. Episode boundaries and attribution rules must be explicit.
3. Cost reduction should be conditional on safety, outcomes, experience, and equity.
4. Risk adjustment and stop-loss provisions reduce incentives for patient selection.
5. Patients need understandable information about both the episode and their own financial responsibility.
6. Early performance data should be interpreted cautiously and reviewed for unintended consequences.

12. Managerial Best Practices

Healthcare organizations can strengthen pricing and reimbursement by adopting the following practices:

• maintain a service-level cost and capacity model;
• analyze net revenue rather than list charges alone;
• segment patients and payers by needs, benefits, and sensitivity;
• publish clear estimates for elective care;
• include patient financial burden in service design;
• negotiate contracts using reliable quality and cost data;
• risk-adjust payment arrangements and protect against catastrophic cases;
• balance financial metrics with outcomes, experience, safety, and equity;
• audit coding, denials, billing accuracy, and collection practices;
• involve clinicians, finance, legal, compliance, patients, and community representatives in major decisions;
• test pricing changes before broad implementation where feasible; and
• review whether incentives produce unintended clinical behavior.

Challenges and Limitations

Pricing analysis is constrained by incomplete cost accounting, inconsistent quality measures, uncertain demand, changing regulation, and fragmented data. Average costs can conceal variation among patients. Historical prices may reflect bargaining power rather than value. Elasticity estimates may confuse price effects with changes in quality, access, or seasonality. Value-based contracts may shift risk without improving care if measures are poorly designed. Finally, a financially attractive price can still be socially harmful if it reduces access or encourages unnecessary treatment.

Sound decision-making therefore combines quantitative analysis with clinical evidence, patient perspectives, legal review, ethical reasoning, and continuous monitoring. No single pricing model is universally superior. The appropriate model depends on the service, the payer, the degree of uncertainty, the organization’s capabilities, and the outcomes society wishes to promote.

Chapter Summary

Healthcare pricing links cost, demand, competition, perceived value, payer design, and ethical responsibility. Cost-based pricing provides a financial floor but may ignore demand and patient value. Competition-based pricing uses market reference points but can be misleading when services or quality differ. Demand-based pricing responds to variation in willingness to pay and urgency, while elasticity helps estimate how utilization may respond to price. Value-based pricing relates payment to outcomes, experience, convenience, and total cost of care.

Managers must distinguish list price, contracted price, and patient responsibility. Transparency improves informed choice but does not by itself ensure affordability. Insurance reduces financial risk while altering utilization and provider incentives. Fee-for-service, capitation, case-based payment, bundles, and value-based contracts distribute risk differently and require appropriate controls.

Effective reimbursement design uses reliable cost and outcome data, risk adjustment, quality safeguards, equity monitoring, and clear governance. Ethical pricing avoids exploitation, discrimination, surprise charges, and incentives that compromise clinical independence. Technology and AI can improve forecasting and administration, but they must be transparent, privacy-preserving, monitored for bias, and subject to human oversight. The central managerial task is to create sustainable payment arrangements that improve health outcomes and access rather than merely increase transactions.

Key Terms

Affordability: The extent to which a patient or household can obtain care without unacceptable financial hardship.

Bundled payment: A single payment for services associated with a defined clinical episode and time period.

Capitation: A fixed payment per enrolled person for a specified period, often adjusted for risk.

Case-based payment: Payment based on the classification and expected resource use of a patient episode.

Co-insurance: The percentage of an allowed healthcare cost paid by the patient.

Co-payment: A fixed amount paid by the patient for a covered service.

Contribution margin: Price or net reimbursement minus variable cost per service.

Cost-plus pricing: Pricing that adds a specified margin or markup to a cost base.

Deductible: The amount a patient pays before specified insurance benefits begin.

Fee-for-service: Payment for each separately billed service or item.

List price: The stated charge before contractual adjustments or patient-specific coverage.

Price elasticity of demand: The percentage change in quantity demanded divided by the percentage change in price.

Price transparency: Clear communication of expected charges, coverage, assumptions, and patient responsibility.

Risk adjustment: Modification of payment or performance comparisons to account for differences in patient complexity.

Shared savings: An arrangement in which providers receive part of savings achieved against a benchmark, usually subject to quality requirements.

Value-based care: Care and payment arrangements designed to improve outcomes and experience relative to cost.

Value-based pricing: Setting price in relation to benefits created for patients, payers, providers, or society.

Out-of-pocket maximum: A contractual limit on specified patient spending during a coverage period.

Review Questions

Short Answer Questions

1. Distinguish list price, contracted price, and patient responsibility.
2. What are two limitations of cost-plus pricing in healthcare?
3. Define price elasticity of demand and explain the meaning of an absolute elasticity greater than one.
4. State two ethical risks associated with opaque healthcare pricing.
5. Why is risk adjustment important in capitation and bundled-payment contracts?

Long Answer Questions

1. Compare cost-based, competition-based, demand-based, and value-based pricing. Explain when each is most appropriate.
2. Analyze how insurance and patient cost sharing influence healthcare utilization and provider behavior.
3. Compare fee-for-service, capitation, case-based payment, bundled payment, and value-based contracts.
4. Explain how a healthcare organization can improve price transparency without creating false certainty about final bills.
5. Discuss the governance requirements for using AI in healthcare pricing and reimbursement.

Analytical / Application Questions

1. A clinic has fixed annual costs of $300,000, a net reimbursement of $120 per visit, and a variable cost of $45 per visit. Calculate the contribution margin and break-even volume. State the assumptions behind your calculation.
2. A hospital is considering a 90-day cardiac-care bundle. Design the episode definition, quality measures, risk-adjustment safeguards, and patient communication requirements.
3. A provider proposes charging higher prices for urgent elective appointments based on real-time demand. Evaluate the proposal using economic, operational, legal, and ethical criteria.

Multiple Choice Questions with Answers

Question 1

Which pricing approach begins with the resources required to deliver a service and adds a margin?

A. Cost-based pricing

B. Competition-based pricing

C. Demand-based pricing

D. Value-based pricing

Correct Answer: A. Cost-based pricing

Question 2

A service has a price of $80 and a variable cost of $32. What is its contribution margin per service?

A. $32

B. $48

C. $80

D. $112

Correct Answer: B. $48

Question 3

If the absolute value of price elasticity of demand is greater than 1, demand is described as:

A. Perfectly inelastic

B. Inelastic

C. Elastic

D. Unit elastic

Correct Answer: C. Elastic

Question 4

Which payment model pays a fixed amount per enrolled person for a specified period?

A. Fee-for-service

B. Capitation

C. Co-payment

D. Case-mix coding

Correct Answer: B. Capitation

Question 5

What is the principal purpose of risk adjustment in reimbursement?

A. To eliminate all provider financial risk

B. To account for differences in patient complexity

C. To guarantee that every patient uses the same services

D. To replace quality measurement

Correct Answer: B. To account for differences in patient complexity

Question 6

Which statement best describes a bundled payment?

A. A separate payment for every item used

B. A fixed payment for a defined clinical episode and period

C. A patient-paid insurance premium

D. A payment based only on provider seniority

Correct Answer: B. A fixed payment for a defined clinical episode and period

Question 7

Which is an ethical requirement of effective price transparency?

A. Displaying only the highest possible charge

B. Hiding contractual discounts from patients

C. Explaining assumptions and expected patient responsibility

D. Guaranteeing an exact final bill despite clinical uncertainty

Correct Answer: C. Explaining assumptions and expected patient responsibility

Question 8

A program has fixed costs of $240,000 and a contribution margin of $48 per consultation. What is its break-even volume?

A. 2,400 consultations

B. 4,000 consultations

C. 5,000 consultations

D. 11,520 consultations

Correct Answer: C. 5,000 consultations

Question 9

Which is a major risk of narrow pay-for-performance measures?

A. They always eliminate administrative costs

B. They can encourage attention to measured outcomes while neglecting unmeasured care

C. They prevent all patient selection

D. They remove the need for clinical judgment

Correct Answer: B. They can encourage attention to measured outcomes while neglecting unmeasured care

Question 10

Value-based pricing primarily relates price to:

A. The provider’s historical list price only

B. The number of employees in the organization

C. Benefits and outcomes relative to alternatives and resources used

D. The patient’s diagnosis without considering outcomes

Correct Answer: C. Benefits and outcomes relative to alternatives and resources used